Advanced (Stage IIIB or IV) or Recurrence non-small cell lung cancers
Conditions
Interventions
Patients will be given cognitive behavioral intervention to support symptom management, led by nurses focusing on the Pain cluster and Fatigue / anorexia cluster: face-to-face (once at the first occas
then by phone (5 times) over 10 weeks.
Sponsors
Asahikawa Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with primary lung cancer, non-small cell lung cancers that are unresectable, at advanced stages (IIIB or IV), or due to recurrence after the second line of standard therapies. 2. Patients who were not diagnosed with other cancers during the previous one year at the time of giving consent. 3. Patients evaluated by physicians as having no un-endurable physical and/or mental pain, and with no cognitive impairment at the time of referral. 4. Patients signing the consent form by their own decision after receiving a detailed explanation about the study participation in writing and orally. 5. PS 0-1 6. Patients with symptoms rated as 1 or higher either in: the tiredness/lack of appetite clusters (loss of appetite, drowsiness, tiredness (fatigue), altered sense of taste, dry mouth), or in the pain clusters (pain, anxiety, sadness), as evaluated at the baseline.
Exclusion criteria
Exclusion criteria: 1. Patients evaluated by physicians to have difficulty in understanding and answering questions due to hearing or cognitive impairment. 2. Patients evaluated to have un-endurable physical and/or mental pain at the time of referral or when deciding on the study participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Symptom severity of each Symptom cluster at the 4 time-points (baseline, 1, 2, and 10 weeks after intervention) 2. Dropout rate of participating patients at the 4 time-points (baseline, 1, 2, and 10 weeks after intervention), with reasons for dropout based on a qualitative analysis of phone communications. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Interference with daily life due to symptoms at the 4 time-points (baseline, 1, 2, and 10 weeks after intervention) 2. QOL (EORTC-QLQC30+LC13) at the 4 time-points (baseline, 1, 2, and 10 weeks after intervention) 3.No. of emergency department visits (baseline, beginning of intervention to 10 weeks) | — |
Countries
Japan
Contacts
Public ContactTamami Hamada
Asahikawa Medical University Department of Nursing
Outcome results
None listed